The Department of Health and Human Services announces changes to the composition of three of the six subcommittees of the Tick-Borne Disease Working Group (Working Group). The changes were made in response to three members who did not accept the invitations they received to be a part of a subcommittee. New members were selected from […]
Govt. Departments & Policies
The departments and agencies of the federal government often play a role in Lyme disease. They may issue policies, guidelines, advisories, or other information which may be useful to Lyme patients, doctors, or the general public. LDA may link to or list some of those government publications which it feels may be important. Complete agency or department information on Lyme disease may be found on each individual agency/department website.
Candy Brassard, Senior Biologist, U.S. Environmental Protection Agency Office of Pesticide Programs; C. Ben Beard, PhD, Director, Bacterial Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control & Prevention at a Meeting at EPA on Lyme in Virginia in 2006.
The U.S. Food and Drug Administration (FDA) has approved the first tests to screen human plasma and whole blood samples for the Babesia parasite species, Babesia Microti (B. Microti), the main species that causes infection in the United States. Babesia parasites are transmitted by Ixodes scapularis ticks, also known as blacklegged or deer ticks but […]
NBC News 4 New York aired a piece on the federal Tick-Borne Working Group, Tri-State Helps Bring Hope to Lyme Wars Public Health Crisis, on February 21, 2018. The video featured LDA President, Pat Smith; Lyme Society, Inc. President, Bob Sabatino; John Aucott, Co-Chair of the Working Group; as well as a number of patients. […]
The Lyme Disease Association announces that the Department of Health and Human Services (HHS) has selected 53 individual to serve on one of six subcommittees of the Tick-Borne Disease Working Group (Working Group). After reviewing the nominations, selections were made by the co-chairs overseeing each of the subcommittees. The Chair and Vice-Chair of the Working Group […]
The Lyme Disease Association Inc. announces that the new HHS Tick-Borne Disease Working Group (TBDWG) has selected co-chairs from the TBDWG for its 6 newly formed sub-committees. LDA President Pat Smith will be co-chair the Disease Vectors, Surveillance and Prevention (includes epidemiology of tick-borne diseases) Subcommittee. The other co-chair is Dr. Ben Beard, Acting Deputy […]
The new HHS Tick-Borne Disease Working Group (TBDWG) is seeking nominations from federal employees and members of the public who are interested in being considered for appointments to subcommittees being established to provide information for the TBDWG. Nominations will be accepted until midnight on January 7, 2018. The new HHS Tick-Borne Disease Working Group (TBDWG) […]
The Lyme Disease Association (LDA) reports that the U.S. Department of Health and Human Services announced on November 22, 2017, the appointment of 14 members, 7 federal and 7 non-federal, to the new HHS Tick-Borne Disease Working Group. Lyme Disease Association President Pat Smith was one of 7 non-federal appointees to the Working Group, which was established through […]
Responses are beginning to come in from organizations and doctors regarding CDC’s limiting of Lyme disease treatments for patients. We will update this list as we continue to receive and review them. As you review each link, if there is an opportunity to respond, please do so. 1) LDA Responds to CDC Limiting Lyme Disease […]
The Lyme Disease Association announced that early today, July 14, the US Department of Health & Human Services (HHS) released its intent to establish the Tick-Borne Disease (TBD) Working Group called for in Section 2062 of the 21st Century Cures Act. The working group will assist HHS in its efforts to conduct and support epidemiological, […]
June 16, 2017 – In an MMWR article highlighting several cases of patients diagnosed with Lyme disease who developed complications including death from the treatment, CDC said it does not recommend prolonged antibiotic or immunoglobulin therapy, which it says, lack data supporting effectiveness for chronic Lyme disease. According to the article entitled “Serious Bacterial Infections […]